These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 35248876

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome.
    Lackner JM, Jaccard J.
    J Consult Clin Psychol; 2021 May; 89(5):435-453. PubMed ID: 34124927
    [Abstract] [Full Text] [Related]

  • 5. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility.
    Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Holroyd K.
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):899-906. PubMed ID: 18524691
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pain Catastrophizing and Clinical Outcomes Among Patients Receiving a Novel Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: An Experimental Therapeutics Approach.
    Roger AH, Gudleski GD, Quigley BM, Zvolensky MJ, Lackner JM.
    Behav Ther; 2023 Jul; 54(4):623-636. PubMed ID: 37330253
    [Abstract] [Full Text] [Related]

  • 9. Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome.
    Lackner JM, Jaccard J, IBS Outcome Study Research Group.
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1500-1508.e3. PubMed ID: 30613000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop FL, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):863-872. PubMed ID: 31492643
    [Abstract] [Full Text] [Related]

  • 13. A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome.
    Owusu JT, Sibelli A, Moss-Morris R, van Tilburg MAL, Levy RL, Oser M.
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14108. PubMed ID: 33745228
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patients' perspectives on GP interactions after cognitive behavioural therapy for refractory IBS: a qualitative study in UK primary and secondary care.
    Sibelli A, Moss-Morris R, Chalder T, Bishop FL, Windgassen S, Everitt H.
    Br J Gen Pract; 2018 Sep; 68(674):e654-e662. PubMed ID: 30061195
    [Abstract] [Full Text] [Related]

  • 18. Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop F, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R, ACTIB trial group.
    Gut; 2019 Sep; 68(9):1613-1623. PubMed ID: 30971419
    [Abstract] [Full Text] [Related]

  • 19. The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.
    Lackner JM, Keefer L, Jaccard J, Firth R, Brenner D, Bratten J, Dunlap LJ, Ma C, Byroads M, IBSOS Research Group.
    Contemp Clin Trials; 2012 Nov; 33(6):1293-310. PubMed ID: 22846389
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.